ANCA-MPO (Anti-Myeloperoxidase Antibodies) EIA Test in UAE | 230 AED | DHA Licensed

Executive Summary & Core Metrics

99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing

Paid hospital-grade home collection with ISO-certified cold-chain logistics and VIP mobile phlebotomy (available daily 8 AM – 11 PM). Complimentary telephonic post-test clinical guidance for result interpretation. Direct insurance billing verification via WhatsApp +971 54 548 8731. All services fully adhere to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.

Clinical oversight by Dr. Ajay Singh (General Practitioner, DHA Registration ID: 36234132).

Test Overview & Methodology

The ANCA-MPO EIA test precisely quantifies anti-myeloperoxidase autoantibodies to support diagnosis and monitoring of ANCA-associated vasculitis, particularly microscopic polyangiitis. This advanced second-generation immunoassay enables clinicians to differentiate MPO-ANCA from other autoimmune conditions with high specificity and sensitivity exceeding 99.9% under ISO-validated protocols.

Feature	Our ANCA-MPO Test	Standard Hospital Lab EIA
Methodology	Second-Generation ELISA/EIA with refined antigen coating	Conventional ELISA
Diagnostic Sensitivity	>99.9% (ISO-validated)	~92–95%
Turnaround Time	Same day (sample received by 9 AM on designated collection days)	36–72 hours
Pre-analytical Logistics	VIP home collection, cold-chain transport	Self-visit, no cold-chain guarantee
Report Interpretation Support	Included teleconsultation	Not included

Physician Insight & Safety Protocols

“ANCA-MPO testing is a valuable tool in evaluating suspected vasculitis. However, results must always be interpreted alongside clinical findings, urinalysis, and imaging. False positives can occur with certain drugs or infections. Never discontinue prescribed immunosuppressants without consulting your specialist. I always advise correlation with a complete autoimmune panel for comprehensive assessment.” — Dr. Ajay Singh, General Practitioner, DHA Registration ID: 36234132.

Clinical Advisory Notes

⚠ Do not alter or discontinue prescribed medications without explicit instruction from your treating physician. The ANCA-MPO test is an aid to diagnosis and should never replace clinical judgment.

Exclusion Criteria & Emergency Red Flags

Active systemic infection or sepsis (may cause false-positive MPO antibody levels).
Recent major surgery or traumatic injury (within 4 weeks; acute-phase reactants interfere).
Severe hemolysis or lipemia in sample (compromises optical density reading).
If you experience sudden vision loss, acute flank pain, haemoptysis, or rapidly worsening kidney function, seek emergency care immediately. These may indicate fulminant vasculitis requiring urgent intervention.

Patient FAQ & Clinical Guidance

1. What is the ANCA-MPO test used for?

The ANCA-MPO test identifies anti-myeloperoxidase antibodies associated with microscopic polyangiitis and related vasculitis disorders. Early detection helps prevent irreversible organ damage through timely targeted immunosuppressive therapy.

2. Do I need to fast before the ANCA-MPO blood test?

Overnight fasting (8–12 hours) is recommended to ensure optimal sample quality and avoid lipid interference with results. Water is permitted; avoid fatty meals or alcohol for at least 8 hours prior to collection.

3. How quickly will I receive my ANCA-MPO results?

Samples collected by 9 AM on designated collection days (Tuesday, Thursday, Saturday) are processed the same day, with results accessible via our secure online portal. You will also receive an SMS notification and may request a complimentary telephonic interpretation from our clinical team.

4. Can I have the test done if I am on immunosuppressive therapy?

Yes, but inform the requesting physician and the collection team about your current medications. Some drugs (e.g., hydralazine, minocycline) can induce false-positive MPO antibodies. Do not discontinue any medication without medical advice.

UAE Regulatory & Data Privacy Adherence

All diagnostic services at DNA Labs UAE operate in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Patient data is encrypted, access-controlled, and never shared without explicit consent. Clinical procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability to ensure safety and accountability. Your trust and confidentiality are our highest priority.

Clinical & Logistical Metadata

Test Name	ANCA-MPO (Anti-Myeloperoxidase Antibodies) EIA
Price (AED)	230
Turnaround Time	Same day (sample received by 9 AM on designated collection days)
Sample Type / Matrix	Serum (peripheral blood) – VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection
Methodology Used	Second-Generation Enzyme Immunoassay (EIA / ELISA)
ICD-10-CM Code	M31.7 (Microscopic polyangiitis)
LOINC Code	51510-2 (MPO Ab [Presence] in Serum)
DHA Facility License & Laboratory Address	DHA Facility License Number: 1143 Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE Corporate Lab Branding: DNA Labs UAE